Cancer statistics, CA Cancer J Clin, vol.66, p.26742998, 2016. ,
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol Off J Eur Soc Med Oncol, vol.29, p.30285222, 2018. ,
Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer, Psychooncology, vol.11, p.12476429, 2002. ,
The relationship between cigarette smoking and quality of life after lung cancer diagnosis, Chest, vol.126, p.15596667, 2004. ,
Smoking cessation interventions in cancer care: opportunities for oncology nurses and nurse scientists, Annu Rev Nurs Res, vol.27, p.20192107, 2009. ,
Tobacco use outcomes among patients with lung cancer treated for nicotine dependence, J Clin Oncol Off J Am Soc Clin Oncol, vol.20, p.12177107, 2002. ,
Prognostic value of smoking status in operated non-small cell lung cancer, Lung Cancer Amst Neth, vol.47, p.15713518, 2005. ,
The effect of preoperative smoking cessation or preoperative pulmonary rehabilitation on outcomes after lung cancer surgery: a systematic review, Clin Lung Cancer, vol.14, p.23017983, 2013. ,
Smoking and timing of cessation on postoperative pulmonary complications after curative-intent lung cancer surgery, J Cardiothorac Surg, vol.12, p.28629433, 2017. ,
Effects of smoking on the pharmacokinetics of erlotinib, Clin Cancer Res Off J Am Assoc Cancer Res, vol.12, pp.2166-2171, 2006. ,
Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers, J Clin Oncol Off J Am Soc Clin Oncol, vol.27, p.19164205, 2009. ,
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer Oxf Engl, vol.45, p.19097774, 1990. ,
Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced nonsmall-cell lung cancer: US Food and Drug Administration trial-level and patient-level analyses, J Clin Oncol Off J Am Soc Clin Oncol, vol.33, p.25667291, 2015. ,
Progression-Free Survival, Response Rate, and Disease Control Rate as Predictors of Overall Survival in Phase III Randomized Controlled Trials Evaluating the First-Line Chemotherapy for Advanced, Locally Advanced, and Recurrent Non-Small Cell Lung Carcinoma, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, vol.11, p.27178983, 2016. ,
Lung Cancer Symptom Scale outcomes in relation to standard efficacy measures: an analysis of the phase III study of pemetrexed versus docetaxel in advanced non-small cell lung cancer, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, vol.3, p.18166838, 2008. ,
, Plasma cotinine and response to chemotherapy in advanced NSCLC
, , 2019.
nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy, Lung Cancer Auckl NZ, vol.8, p.29138610, 2017. ,
Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin, Clin Lung Cancer, vol.19, p.29903552, 2018. ,
Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer, Cancer, vol.106, p.16634096, 2006. ,
The cigarette burden (measured by the number of pack-years smoked) negatively impacts the response rate to platinum-based chemotherapy in lung cancer patients, Lung Cancer Amst Neth, vol.61, p.18243408, 2008. ,
Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinic, Biomark Biochem Indic Expo Response Susceptibility Chem, vol.8, p.12944174, 2003. ,
Accuracy of self-reported tobacco use in newly diagnosed cancer patients, Cancer Causes Control CCC, vol.24, p.23553611, 2013. ,
Comparison between objective measures of smoking and self-reported smoking status in patients with asthma or COPD: are our patients telling us the truth?, J Bras Pneumol Publicacao Of Soc Bras Pneumol E Tisilogia, vol.41, p.25972966, 2015. ,
Cotinine as a biomarker of environmental tobacco smoke exposure, Epidemiol Rev, vol.18, p.9021312, 1996. ,
, Biochemical verification of tobacco use and cessation, Nicotine Tob Res Off J Soc Res Nicotine Tob, vol.4, p.12028847, 2002.
Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines, Int J Cancer, vol.124, p.18844224, 2009. ,
Nicotine induces self-renewal of pancreatic cancer stem cells via neurotransmitter-driven activation of sonic hedgehog signalling, Eur J Cancer Oxf Engl, vol.52, p.26689865, 1990. ,
Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer, Am J Respir Cell Mol Biol, vol.40, p.18676776, 2009. ,
Nicotine inactivation of the proapoptotic function of Bax through phosphorylation, J Biol Chem, vol.280, p.15642728, 2005. ,
Nicotine increases the resistance of lung cancer cells to cisplatin through enhancing Bcl-2 stability, Br J Cancer, vol.110, p.24548862, 2014. ,
Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin, Proc Natl Acad Sci, vol.103, p.16601104, 2006. ,
Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Carcinoma, Clin Lung Cancer, vol.17, p.26762562, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01251414
Membrane-bound full-length Sonic Hedgehog identifies cancer stem cells in human non-small cell lung cancer, Oncotarget, vol.8, p.29262597, 2017. ,
Influence of smoking on the pharmacokinetics and toxicity profiles of taxane therapy, Clin Cancer Res Off J Am Assoc Cancer Res, vol.18, p.22645049, 2012. ,
Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia, J Clin Oncol Off J Am Soc Clin Oncol, vol.25, p.17563393, 2007. ,
Cigarette smoking and gemcitabine-induced neutropenia in advanced solid tumors, Oncology, vol.85, p.24080957, 2013. ,
Long-term nicotine replacement therapy: cancer risk in context, Cancer Prev Res Phila Pa, vol.4, p.22052338, 2011. ,